ArticleBreast cancer research and treatment2026

Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen.

Riya Albert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.